NASDAQ:ACRS

Aclaris Therapeutics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy ACRS

*Your capital is at risk

$5.20

-0.120 (-2.26%)

At Close: Jul 31, 2026

Aclaris Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 35.04. In total, the insiders bought 6.24M and sold 449.42K ACRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	35.04
● Buy	6.24M shares
● Sell	449.42K shares
85% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Apr 23, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 35.04. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 02, 2026 Buy	Restricted Stock Units A-Award	Walker Neal CEO	CEO / President	274 800 Value: $992.0K
Feb 02, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Walker Neal CEO	CEO / President	961 700 Value: $3.47M
Feb 02, 2026 Buy	Restricted Stock Units A-Award	Davis Hugh M. President And COO	CEO / President	96 100 Value: $346.9K
Feb 02, 2026 Buy	Employee Stock Option (Right to Buy) A-Award	Kolbeck Roland Wilhelm Chief Scientific Officer	Officer	334 900 Value: $1.21M
Feb 01, 2026 Buy	Restricted Stock Units M-Exempt	Loerop James Chief Business Officer	Officer	11 250 Value: $58.5K
Feb 01, 2026 Buy	Resticted Stock Units M-Exempt	Loerop James Chief Business Officer	Officer	7 500 Value: $39.0K
Feb 01, 2026 Buy	Restricted Stock Units M-Exempt	Loerop James Chief Business Officer	Officer	14 750 Value: $76.7K
Feb 01, 2026 Buy	Common Stock M-Exempt	Loerop James Chief Business Officer	Officer	7 500 Value: $39.0K
Feb 01, 2026 Buy	Common Stock M-Exempt	Loerop James Chief Business Officer	Officer	14 750 Value: $76.7K
Feb 01, 2026 Sell	Common Stock F-InKind	Loerop James Chief Business Officer	Officer	10 686 Value: $37.5K
Feb 01, 2026 Buy	Common Stock M-Exempt	Loerop James Chief Business Officer	Officer	11 250 Value: $58.5K
Feb 01, 2026 Buy	Restricted Stock Units M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	14 750 Value: $76.7K
Feb 01, 2026 Sell	Common Stock F-InKind	Balthaser Kevin Chief Financial Officer	C-Suite Officer	4 984 Value: $17.5K
Feb 01, 2026 Buy	Common Stock M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	14 750 Value: $76.7K
Jan 02, 2026 Buy	Restricted Stock Units M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	13 200 Value: $38.0K
Jan 02, 2026 Buy	Common Stock M-Exempt	Walker Neal CEO	CEO / President	29 150 Value: $84.0K
Jan 02, 2026 Sell	Common Stock F-InKind	Walker Neal CEO	CEO / President	9 952 Value: $28.7K
Jan 02, 2026 Buy	Restricted Stock Units M-Exempt	Walker Neal CEO	CEO / President	29 150 Value: $84.0K
Jan 02, 2026 Buy	Common Stock M-Exempt	Loerop James Chief Business Officer	Officer	18 150 Value: $52.3K
Jan 02, 2026 Sell	Common Stock F-InKind	Loerop James Chief Business Officer	Officer	6 171 Value: $17.8K
Jan 02, 2026 Buy	Restricted Stock Units M-Exempt	Loerop James Chief Business Officer	Officer	18 150 Value: $52.3K
Jan 02, 2026 Buy	Common Stock M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	13 200 Value: $38.0K
Jan 02, 2026 Sell	Common Stock F-InKind	Balthaser Kevin Chief Financial Officer	C-Suite Officer	4 461 Value: $12.8K
Jan 01, 2026 Buy	Restricted Stock Units M-Exempt	Balthaser Kevin Chief Financial Officer	C-Suite Officer	7 500 Value: $39.0K
Jan 01, 2026 Sell	Common Stock F-InKind	Balthaser Kevin Chief Financial Officer	C-Suite Officer	2 250 Value: $7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks